Published in

Elsevier, Annals of Oncology, 11(33), p. 1186-1199, 2022

DOI: 10.1016/j.annonc.2022.07.008

Links

Tools

Export citation

Search in Google Scholar

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO